Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2025 to Q4 2025

Type / Class
Equity / Class A ordinary shares, par value $0.0001 per share
Symbol
TDAC on Nasdaq
Shares outstanding
17,244,009
Price per share
$10.49
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,672,459
Total reported value
$69,890,387
% of total 13F portfolios
0%
Share change
-848,648
Value change
-$8,809,193
Number of holders
23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WOLVERINE ASSET MANAGEMENT LLC 9% +15% $16,069,623 +$2,089,212 1,557,134 +15% WOLVERINE ASSET MANAGEMENT LLC 30 Sep 2025
AQR CAPITAL MANAGEMENT LLC 6.4% -25% $11,087,889 -$3,880,911 1,099,989 -26% AQR Capital Management, LLC 31 Mar 2025
BANK OF MONTREAL /CAN/ 4.6% -19% $8,240,000 -$2,060,000 800,000 -20% Bank of Montreal 30 Jun 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 2.3% -58% $4,032,000 -$5,040,000 400,000 -56% Healthcare of Ontario Pension Plan Trust Fund 31 Mar 2025

As of 31 Dec 2025, 23 institutional investors reported holding 6,672,459 shares of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC). This represents 39% of the company’s total 17,244,009 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) together control 40% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
WOLVERINE ASSET MANAGEMENT LLC 7.9% 1,367,115 -12% 0.2% $14,341,036
Hudson Bay Capital Management LP 3.8% 650,000 0% 0.04% $6,818,500
First Trust Capital Management L.P. 3.8% 649,998 0% 0.41% $6,818,479
PICTON MAHONEY ASSET MANAGEMENT 2.8% 475,002 0% 0.05% $4,975,646
Periscope Capital Inc. 2.3% 400,090 0% 0.81% $4,190,943
Glazer Capital, LLC 2.3% 399,797 -3.3% 0.11% $4,182,000
GOLDMAN SACHS GROUP INC 2.2% 385,010 0% 0% $4,027,205
MIZUHO SECURITIES USA LLC 2.1% 366,110 +0.86% 0.06% $3,789,239
MMCAP International Inc. SPC 2% 350,000 0% 0.37% $3,671,500
Westchester Capital Management, LLC 1.4% 248,852 0% 0.12% $2,610,458
Wealthspring Capital LLC 1.2% 207,230 0% 0.51% $2,167,626
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 1.2% 200,000 0% 0.01% $2,095,000
Verition Fund Management LLC 1.1% 191,535 -5% 0.01% $2,009,202
L1 Global Manager Pty Ltd 1% 175,000 0% 1.2% $1,835,750
BERKLEY W R CORP 1% 173,530 0% 0.1% $1,815,124
Centiva Capital, LP 0.87% 150,000 0% 0.1% $1,573,500
DLD Asset Management, LP 0.55% 94,853 0% 0.1% $995,008
GRITSTONE ASSET MANAGEMENT LLC 0.49% 83,651 0% 0.84% $877,499
Warberg Asset Management LLC 0.43% 73,422 0% 0.23% $769,095
GEODE CAPITAL MANAGEMENT, LLC 0.1% 16,554 0% 0% $173,651
UBS Group AG 0.07% 12,683 -63% 0% $132,664
Clear Street Group Inc. 0.01% 1,969 0% 0% $20,655
MORGAN STANLEY 0% 58 +383% 0% $607
Karpus Management, Inc. 0% 0 -100% $0
Crossingbridge Advisors, LLC 1.4% 250,000 0% $250,000

Institutional Holders of Translational Development Acquisition Corp. - Class A ordinary shares, par value $0.0001 per share (TDAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,672,459 $69,890,387 -$8,809,193 $10.49 23
2025 Q3 15,031,948 $155,536,911 +$15,253,748 $10.35 40
2025 Q2 13,959,688 $142,484,311 +$30,107,600 $10.27 38
2025 Q1 11,160,102 $112,476,282 +$112,476,282 $10.08 30